|

TGX-007 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Trogenix ltd1

Indications

  • High Grade Gliomas1
  • Newly Diagnosed Glioblastoma1
  • Glioblastoma (GBM)1
  • Recurrent Glioblastoma1
  • Cancer1

Columbus, Ohio1 trial

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Ohio State University Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.